United States · Platforms & data · Yahoo Finance

Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*

Published by Yahoo Finance · United States 9 h ago

Solventum (NYSE: SOLV), a leader in advanced wound healing, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the combined use of…

Read the full article on Yahoo Finance Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)

Also worth reading

Seeking Alpha

Haemonetics wins approval of PerQseal Elite vascular closure system

The Motley Fool

Worried About the Stock Market? This High-Yielding ETF Can Provide Stability and Generate Passive Income for Decades

MarketWatch

Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.

Investing.com

US set to announce certification of Boeing 737 MAX 10 on Tuesday, sources say

CNBC

Anthropic is AI trade's last big hope for a major IPO this year

Stocktwits